Skip to main content
Journal cover image

Prognostic Value of the PARIS Thrombotic Risk Score for 2-Year Mortality After Percutaneous Coronary Intervention.

Publication ,  Journal Article
Zhao, X; Li, J; Tang, X; Xian, Y; Jiang, L; Chen, J; Gao, L; Gao, Z; Qiao, S; Yang, Y; Gao, R; Xu, B; Yuan, J
Published in: Clin Appl Thromb Hemost
2019

The Patterns of non-Adherence to Anti-Platelet Regimen in Stented Patients (PARIS) thrombotic risk score is a novel score for predicting the risk of coronary thrombotic events after percutaneous coronary intervention (PCI). We assessed the prognostic value of this score for mortality in patients with PCI. In this prospective, observational study, we enrolled 10 724 consecutive patients underwent PCI. The primary end point was all-cause death and the secondary end point was major adverse cardiovascular and cerebrovascular events (MACCE) as a composite of all-cause death, myocardial infarction, revascularization, stent thrombosis, or stroke. Among 9782 patients without in-hospital events, a total of 97 deaths and 1002 MACCE occurred during the 2-year follow-up. The mortality risk of patients in the high-risk group was 2.31 times higher than that in the low-risk group (hazard ratio, 2.31; P = .001). This risk score showed prognostic value in evaluating mortality (area under the receiver operating characteristic curve [AUROC], 0.607; 95% confidence interval [CI], 0.551-0.663) and MACCE (AUROC, 0.544; 95% CI, 0.526-0.563; both P < .001). The prognostic value of mortality was higher than that of MACCE (Z = 2.09, P = .04). The PARIS thrombotic risk score shows modest prognostic value for mortality and MACCE, and the prognostic value of mortality is better than that of MACCE.

Duke Scholars

Published In

Clin Appl Thromb Hemost

DOI

EISSN

1938-2723

Publication Date

2019

Volume

25

Start / End Page

1076029619853638

Location

United States

Related Subject Headings

  • Thrombosis
  • Risk Assessment
  • ROC Curve
  • Prospective Studies
  • Prognosis
  • Percutaneous Coronary Intervention
  • Mortality
  • Middle Aged
  • Male
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zhao, X., Li, J., Tang, X., Xian, Y., Jiang, L., Chen, J., … Yuan, J. (2019). Prognostic Value of the PARIS Thrombotic Risk Score for 2-Year Mortality After Percutaneous Coronary Intervention. Clin Appl Thromb Hemost, 25, 1076029619853638. https://doi.org/10.1177/1076029619853638
Zhao, Xueyan, Jianxin Li, Xiaofang Tang, Ying Xian, Lin Jiang, Jue Chen, Lijian Gao, et al. “Prognostic Value of the PARIS Thrombotic Risk Score for 2-Year Mortality After Percutaneous Coronary Intervention.Clin Appl Thromb Hemost 25 (2019): 1076029619853638. https://doi.org/10.1177/1076029619853638.
Zhao X, Li J, Tang X, Xian Y, Jiang L, Chen J, et al. Prognostic Value of the PARIS Thrombotic Risk Score for 2-Year Mortality After Percutaneous Coronary Intervention. Clin Appl Thromb Hemost. 2019;25:1076029619853638.
Zhao, Xueyan, et al. “Prognostic Value of the PARIS Thrombotic Risk Score for 2-Year Mortality After Percutaneous Coronary Intervention.Clin Appl Thromb Hemost, vol. 25, 2019, p. 1076029619853638. Pubmed, doi:10.1177/1076029619853638.
Zhao X, Li J, Tang X, Xian Y, Jiang L, Chen J, Gao L, Gao Z, Qiao S, Yang Y, Gao R, Xu B, Yuan J. Prognostic Value of the PARIS Thrombotic Risk Score for 2-Year Mortality After Percutaneous Coronary Intervention. Clin Appl Thromb Hemost. 2019;25:1076029619853638.
Journal cover image

Published In

Clin Appl Thromb Hemost

DOI

EISSN

1938-2723

Publication Date

2019

Volume

25

Start / End Page

1076029619853638

Location

United States

Related Subject Headings

  • Thrombosis
  • Risk Assessment
  • ROC Curve
  • Prospective Studies
  • Prognosis
  • Percutaneous Coronary Intervention
  • Mortality
  • Middle Aged
  • Male
  • Humans